Literature DB >> 14743872

Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo.

Soumya Mitra1, Evan M Goren, John G Frelinger, Thomas H Foster.   

Abstract

Cellular responses to photodynamic therapy (PDT) include induction of heat shock proteins (HSP). We examined meso-tetrahydroxyphenyl chlorin (mTHPC) PDT-mediated HSP activation in EMT6 cells stably transfected with a plasmid containing the gene for green fluorescent protein (GFP) driven by an hsp70 promoter. mTHPC incubation induced concentration-dependent GFP expression. Irradiation of cells exposed to a sensitizer concentration that induced a slight increase in GFP and no loss of cell viability resulted in fluence-dependent GFP accumulation. In response to drug only and to PDT, GFP levels increased to a maximum of four- to five-fold above control levels with increasing drug or fluence and then decreased at higher doses. A trypan blue-exclusion assay confirmed that decreased GFP levels in both cases were due to a loss of cell viability. For initial evaluation in vivo, HSP70/ GFP-transfected EMT6 tumors were grown in BALB/c mice and subjected to mTHPC-PDT with a fluence of 1 J/cm2. Six hours after PDT, GFP fluorescence was imaged in these tumors through the intact skin in vivo. These results indicate that sublethal doses of mTHPC-PDT stimulate GFP expression under the control of an hsp70 promoter and illustrate the potential of noninvasively monitoring reporter protein fluorescence as a measure of molecular response to PDT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14743872     DOI: 10.1562/0031-8655(2003)078<0615:aohspp>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  13 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  Cancer Cell-targeted and Activatable Photoimmunotherapy Spares T Cells in a 3D Coculture Model.

Authors:  Eric M Kercher; Shubhankar Nath; Imran Rizvi; Bryan Q Spring
Journal:  Photochem Photobiol       Date:  2019-10-13       Impact factor: 3.421

Review 4.  Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments.

Authors:  Srivalleesha Mallidi; Bryan Q Spring; Tayyaba Hasan
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

Review 5.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

6.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

7.  Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70.

Authors:  Soumya Mitra; Benjamin R Giesselman; Francisco J De Jesús-Andino; Thomas H Foster
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

8.  Development of rapid and highly sensitive HSPA1A promoter-driven luciferase reporter system for assessing oxidative stress associated with low-dose photodynamic therapy.

Authors:  Yuanhong Zheng; Vanminh Le; Zhuoan Cheng; Sheng Xie; Hegeng Li; Jianhui Tian; Jianwen Liu
Journal:  Cell Stress Chaperones       Date:  2012-11-18       Impact factor: 3.667

9.  Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response.

Authors:  Angelika Szokalska; Marcin Makowski; Dominika Nowis; Grzegorz M Wilczynski; Marek Kujawa; Cezary Wójcik; Izabela Mlynarczuk-Bialy; Pawel Salwa; Jacek Bil; Sylwia Janowska; Patrizia Agostinis; Tom Verfaillie; Marek Bugajski; Jan Gietka; Tadeusz Issat; Eliza Glodkowska; Piotr Mrówka; Tomasz Stoklosa; Michael R Hamblin; Pawel Mróz; Marek Jakóbisiak; Jakub Golab
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.

Authors:  Ken Kang-Hsin Wang; Soumya Mitra; Thomas H Foster
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.